Royal London Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $550M | Sell |
|
|||||
2025
Q1 | $643M | Buy |
|
|||||
2024
Q4 | $572M | Buy |
|
|||||
2024
Q3 | $640M | Sell |
|
|||||
2024
Q2 | $711M | Sell |
|
|||||
2024
Q1 | $661M | Sell |
|
|||||
2023
Q4 | $519M | Sell |
|
|||||
2023
Q3 | $487M | Sell |
|
|||||
2023
Q2 | $593M | Buy |
|
|||||
2023
Q1 | $397M | Buy |
|
|||||
2022
Q4 | $398M | Buy |
|
|||||
2022
Q3 | $297M | Sell |
|
|||||
2022
Q2 | $305M | Buy |
|
|||||
2022
Q1 | $240M | Buy |
|
|||||
2021
Q4 | $226M | Buy |
|
|||||
2021
Q3 | $187M | Sell |
|
|||||
2021
Q2 | $208M | Buy |
|
|||||
2021
Q1 | $164M | Buy |
|
|||||
2020
Q4 | $143M | Buy |
|
|||||
2020
Q3 | $121M | Buy |
|
|||||
2020
Q2 | $111M | Sell |
|
|||||
2020
Q1 | $96.5M | Buy |
|
|||||
2019
Q4 | $91.5M | Buy |
|
|||||
2019
Q3 | $76.2M | Buy |
|
|||||
2019
Q2 | $75.2M | Buy |
|
|||||
2019
Q1 | $84M | Sell |
|
|||||
2018
Q4 | $76.8M | Buy |
|
|||||
2018
Q3 | $55.6M | Sell |
|
|||||
2018
Q2 | $44.8M | Buy |
|
|||||
2016
Q2 | $30.8M | Sell |
|
|||||
2016
Q1 | $244K | Buy |
|
|||||
2015
Q4 | $34.5M | Sell |
|
|||||
2015
Q3 | $33.6M | Buy |
|
|||||
2014
Q4 | $292K | Buy |
|
|||||
2014
Q3 | $22.5M | Buy |
|
|||||
2014
Q2 | $20.3M | Sell |
|
|||||
2014
Q1 | $20M | Buy |
|
|||||
2013
Q4 | $12.8M | Buy |
|
|||||
2013
Q3 | $12.3M | Buy |
|
|||||
2013
Q2 | $12M | Buy |
|